Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bayer To Allocate 10 Million Yuan For Community Health In China

This article was originally published in PharmAsia News

Executive Summary

Bayer HealthCare has announced that, starting this month, it will allocate 10 million yuan ($1.45 billion) for China's community health establishment project, the largest ever between a non-government organization and the Ministry of Health. MOH officials say the project will actively publicize community health services in the next three years, including training administrators, developing and extending suitable practice standards, as well as supporting community health organizations to conduct health education and promotion. Besides Bayer, Johnson & Johnson, Pfizer and Novartis have also participated in such exercises. Industry observers point out that the strategy builds up a favorable image of corporate responsibility on social welfare. The perception will help companies concerned project a reliable reputation, benefiting their bids for drug tenders and their drugs' inclusion in the medicine catalog. (Click here for more - Chinese Language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068851

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel